RecruitingNot ApplicableNCT06102382
The Effect of Two Different Doses of Noradrenaline on Hypotension Caused by Spinal Anesthesia for Cesarean Section
Sponsor
Assiut University
Enrollment
100 participants
Start Date
Sep 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
To compare two infusion rates of norepinephrine for prophylaxis against post-spinal hypotension during caesarean delivery.
Eligibility
Sex: FEMALEMin Age: 19 YearsMax Age: 40 Years
Inclusion Criteria2
- Pregnant women scheduled for cesarean section under spinal anesthesia
- Gestational age of at least 37 weeks
Exclusion Criteria7
- Patient refusal
- Contraindications of spinal anesthesia
- Allergy to the study drug
- Height<150 cm, weight < 60 kg, body mass index (BMI) ≥40 kg/m2.
- patients with cardiac morbidities
- Hypertensive disorders of pregnancy.
- Prepartum hemorrhage
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGNorepinephrine (0.1)
An intravenous bolus dose of norepinephrine (5 µg) followed by infusion of 0.1 µg/kg/min till 5 minutes after delivery of the fetus.
DRUGNorepinephrine (0.075)
An intravenous bolus dose of norepinephrine (5 µg) followed by infusion of 0.075 µg/kg/min till 5 minutes after delivery of the fetus.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06102382
Related Trials
Determining the Optimal Dose of Intrathecal Morphine for Post-Cesarean Analgesia
NCT070234971 location
The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlled Clinical Trial.
NCT072761261 location
Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates
NCT058366101 location
Intra-abdominal Pressure, Abdominal Circumference, and Spinal Block Level in Cesarean Section
NCT074063731 location
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
NCT075114911 location